Experimental immune therapy shows promise against deadly childhood brain cancer
A new treatment method has shown successful results in children with recurrent brain tumors.
1Childhood brain cancer
Brain and spinal cord tumors are among the most deadly cancers in children. Current treatments often offer limited options and present a challenging process for families.
2Experimental T cell therapy
A new immune therapy uses the patient's own T cells to target brain tumors. This treatment shows promise, especially for recurrent tumors.
3Clinical trial results
In an early-stage clinical trial, three children who received the treatment showed no signs of cancer. These children had not responded to years of chemotherapy and radiation.
4How the treatment works
The treatment involves multiplying T cells taken from the patient's blood in a lab and reintroducing them to the patient. These cells recognize proteins in the tumor and activate the immune system.
5Challenges in brain cancer
Completely removing brain tumors can damage areas controlling vital functions. Additionally, the blood-brain barrier prevents drugs from reaching tumors in effective doses.
6Hope for the future
Although this treatment is in its early stages, it could improve survival rates for children. Larger clinical trials are needed to confirm its effectiveness.